Cuadra, Emie Flor T.

HRN: 12-05-55  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
02/28/2023
CEFUROXIME 750MG (VIAL)
02/28/2023
03/07/2023
IVT
750mg
Q8
UTI; Pus Cells: 15-20; Bacteria: Moderate
02/28/2023
CEFUROXIME 1.5GM (VIAL)
02/28/2023
03/01/2023
IVT
1.5g
Q8 X 3 Doses
UTI; Pus Cells: 15-20; Bacteria: Moderate
Waiting Final Action 
03/01/2023
CEFUROXIME 500MG (TAB)
03/01/2023
03/08/2023
PO
500 Mg
BID
UTI
Waiting Final Action 
04/05/2023
CEFUROXIME 500MG (TAB)
04/05/2023
04/11/2023
PO
500mg
BID
Second Degree Laceration
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: